common.study.topics.clinical

Oophorectomy, Estrogen Therapy and Cardiovascular Risk

common.study.values.description

Oophorectomy, Estrogen Therapy and Cardiovascular Disease Risk in Young Women

Researchers are trying to assess the appropriate dose of estrogen for decreasing the risk of cardiovascular disease in women who have removal of their ovaries at a young age, before the age of 46 years.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Estradiol 100 Micrograms Patch

Standard

Drug - Estradiol Patch

Individualized

participant.views.study.view.additional

participant.views.study.view.scientific-title

Impact of Individualized Estrogen Therapy on Cardiovascular Disease Risk Parameters in Young Women After Bilateral Oophorectomy: A Randomized Controlled Trial

common.study.values.clinical-trial-id

NCT03815929

participant.views.study.view.id

dwp7me